OpenAI and Retro Biosciences Deploy GPT-4b micro for Protein Engineering in Longevity Research
OpenAI collaborated with Retro Biosciences to apply a specialized model called GPT-4b micro to protein engineering tasks relevant to stem cell therapy and longevity research. The work represents a concrete application of a fine-tuned or specialized variant of GPT-4 to life sciences, specifically improving protein design effectiveness. This is a notable example of frontier AI models being deployed in wet-lab-adjacent scientific research contexts.
Related guides (3)
Related events (8)
GPT-5 lowers the cost of cell-free protein synthesis
An autonomous laboratory system integrating OpenAI's GPT-5 with Ginkgo Bioworks' cloud automation platform achieved a 40% reduction in cell-free protein synthesis costs. The system operates via closed-loop experimentation, where the AI model iteratively designs, executes, and refines biological experiments without human intervention. This represents a concrete application of frontier LLMs to wet-lab automation and cost optimization in synthetic biology.
OpenAI introduces GPT-Rosalind with life sciences and biological reasoning capabilities
OpenAI announced GPT-Rosalind, a model or product variant targeting life sciences research with enhanced capabilities in biological reasoning, medicinal chemistry, genomics analysis, and experimental workflow support. The announcement positions this as a domain-specialized offering from OpenAI for scientific research applications. This represents OpenAI's continued push into vertical AI for high-value scientific domains.
Introducing GPT-Rosalind for Life Sciences Research
OpenAI has announced GPT-Rosalind, a frontier reasoning model specifically designed for life sciences applications including drug discovery, genomics analysis, protein reasoning, and scientific research workflows. The model represents a domain-specialized deployment of OpenAI's reasoning capabilities targeted at biomedical research. This is a tier-1 lab release with a focused vertical application rather than a general-purpose model launch.
Measuring AI's capability to accelerate biological research
OpenAI introduces a real-world evaluation framework designed to measure how AI systems can accelerate biological research in wet lab settings. The work uses GPT-5 to optimize a molecular cloning protocol as a concrete demonstration case. The framework explicitly addresses both the potential benefits and biosecurity risks of AI-assisted experimentation, positioning this as a dual-use capability assessment.
Medical Research with GPT-5
OpenAI published a blog post describing how GPT-5 is being used for medical research applications. The post appears to be an announcement or case study highlighting GPT-5's capabilities in a healthcare/research context. Specific details about methods, benchmarks, or outcomes are not provided in the available text.
Introducing GPT-4.1 in the API
OpenAI is releasing GPT-4.1, a new family of models available via API to developers worldwide, featuring improvements in coding, instruction following, and long-context understanding. The release also includes GPT-4.1 nano, OpenAI's first nano-scale model. The models are positioned as developer-facing API products rather than consumer-facing releases.
Fine-tuning now available for GPT-4o
OpenAI has launched fine-tuning support for GPT-4o, its flagship multimodal model, as of August 20, 2024. This allows developers to customize GPT-4o on their own datasets via the OpenAI API. The release extends the fine-tuning capability previously available on GPT-3.5 and GPT-4 to the most capable model in OpenAI's lineup, enabling task-specific optimization at the frontier.
GPT-3.5 Turbo fine-tuning and API updates
OpenAI has opened fine-tuning access for GPT-3.5 Turbo, allowing developers to customize the model with their own data for specific use cases. This extends fine-tuning capabilities previously available on older GPT-3 models to the more capable Turbo variant. The announcement also includes associated API updates to support this functionality.